<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 281 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page280.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=281">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 281 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 281</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=281"><img src="../thumb/281.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>244 / 2020-04                                                             Anti-Microbials - 18.7
   hallucinat., psychot.reacts. incl. self-endanger.behav., depress.,   TAVALOXX 250, 500, 750, Cipla Medpro [P/S]  Warnings and special precautions: Seiz. disposit., concom.
   weakn., myalg., tendosynovit., achillotendinit., rupture of Achilles   Levofloxacin.  fenbufen & simil.NSAID’s/ theophyll.& drugs which low.cerebr.seiz.
   tendon. Rare: Joint pain/swell., tachycard., flush., migraine, synco-  Indications: Ac.exacerbat.of chron.bronchit., community acquir.  thresh., tendinit.with poss.Achilles tendon rupture within 48 hrs.or
   pe, Freq. unknown: Naus., diarrh., vomit., dyspeps., abdom. pain,   pneumon., sinusit., complic.UTI & ac. pyelonephrit., uncomplic.UTI   aft.discontin.more common.affect. elderly/ with concom.corticos-
   pseudomembr.colit., vis.disturbs., tinnit., trans. hear.impairm., eo-  in women, uncomplic./complicat. skin & soft tiss.& intra-abdom.  ter., unnecess. expos.to strong sunlight/ UV, diabet., porphyr., poss.
   sinophil., leucocytopen., granulocytopen., anaem., thrombocytopen.,   infects.in adults caus by sens.bact.  false negat. bacteriolog.TB diagn., imp.ren. funct., myasth.grav., ad-
   leucocytos., thrombocytos., haemolyt.anaem., alter. prothromb.val.,   (S4) TABS, 41/20.1.1/0008, 0009  min.tabs.with 2 hr.interv. with iron salts/ antacids & sucralfate, do
   dizzin., headache, tiredn., nervousn., agitat., trembl, crystallur., inter-  709846-001: 500 mg, 5, R178,03  not combine infus.with hepar./other alkaline sols., discont. if pseu-
   stit. nephrit., trans.ren. impairm.incl.trans.ren.fail., haematur., ana-  709847-001: 750 mg, 5, R185,09  domembr.colit.is suspect., Clostrid.diffic.-assoc.diarrh.report., drugs
   phylact./anaphylact.reacts., phlebit/ thrombophlebit., inj.site irrit./  Dosage: Dos.determin.by sev.,type & sens.of infect.  affect. tubul. ren.secret.eg.probenecid & cimetid.esp.in ren. impairm.,
   pain, temp. transaminas./ alkaline phosphatase elev., taste/ smell   RTI’s: 500 mg 1-2xdly.x5-14 days. High.dos.in pres. of complicat.fact.  risk fact.known to prolong QT-interv. eg elderly/uncorr.electrol.bal./
   impairm., hyperglycaem., hepat.necros., superinfect.  UTI’s: Complic: 250 mg 1xdly.x10 days. Uncomplic. in women: 250   congenit.long QT syndr./ card.dis./concom meds, latent/pres. G6PD
   Warnings and Special precautions: Consid. benef.-risk in childr.  mg 1xdly.x3 days.  activ. defects, discont.ther.in case of periph. neuropathy which may
   und.18 yrs./grow.adolesc., convuls. disords.hist., good hydrat.& avoid   Skin & soft tiss.infects: Uncomplic: 250-500 mg 1xdly x7-10   be rapid in onset.
   alkaline urine, elderly, imp.ren./liv.funct., sev.& persist. diarrh., GPD6,   days. Complic: 500 mg 1xdly. x10-14 days.  Drug interactions: Iron preps./Mg & Al hydrox. contain.antacids
   myasth.grav., should be admin.1-2 hrs. bef./4 hrs.aft iron preps/Mg/  Intra-abdom.infects: 500 mg 1xdly.in combinat. with anaerobic   & sucralfate interfer.with absorpt., low.of cerebr.seiz.thresh.when
   Al/Ca hydrox. contain.antacids & sucralfate, monit.concom. theophyll.  antibiot. x10-14 days. In pres.of bacteraem./ septicaem.incr.dos.to   giv.with drugs that low.seiz.thresh.eg.theophylline, fenbufen/ simil.
   plasma lev., monit.INR with warfar., discont. if pseudomembr.colit./  500 mg 2xdly. x10-14 days.  NSAID’s., incr.coagulat.tests &/or bleed. report.in combinat.with vit.K
   achillotendinit. suspect.    Contraindications: Other quinolone hypersens., epilep., ten-  antagon. eg warfar., caut.with probenecid & cimetid., ac.kidn. injur.
   Interactions: Elev.theophyll.plasma conc.& prolongat. of its eliminat.  don disord.hist.assoc.with fluroquinolone admin., childr./adolesc.  with ACE inhibit.& renin.angiotens.recept. block.
   half-life, Fe preps/Mg/ Al/Ca hydrox.contain.antacids & sucralfate   und.18 yrs., pregn., lactat.  UTIN-400, Cipla Medpro [P/S]
   interfer. with absorpt., NSAID’s incr.risk of CNS stimulat. & convuls.  Side effects: Hypersens.reacts.incl.Stev.-Johns./ Lyell’s syndr.&   Norfloxacin.
   seiz., poss.warfar.toxic., act.of glibenclamide poss.intensif., probene-  erythema multiforme, bld.dyscras., hypoglycaem.esp.in diab., CNS   Indications: U&L UTI, cystit., pyelit., cysto-& pyelonephrit.caus.
   cid incr. ciprofloxacin ser.conc., metoclopramide acceler. absorpt., cy-  effs., paresthes., vis./audit./taste & smell disturbs., trem., halluci-  by suscept.bact.
   clospor.incr.ser.creatin.conc.  nat., convuls., psychot.reacts., GI disturbs. incl. sev./bloody diarrh.,   (S4) TABS. 31/20.1.1/0517.
   SANDOZ LEVOFLOXACIN 250; 500, Sandoz [P/S]  hepatit., interstit.nephrit., ac. ren.fail., photosens., tendinit., arthralg.   836338-006: 400 mg, 6, R61,85
                                / myalg., Achilles tend.rupt., musc.weakn.esp.in myasth. grav.pts.,
   Levofloxacin.                rhabdomyolys., anaphylact.-like shock, asthen., superinfect., trigg.  Dosage: Admin.pref.bef.meals x3 days in uncomplic. UTI and x7-
   Indications: Ac.exacerbat.of chron. bronchit., community acquir.  prophyr.attacks in porphyr.pts.  10 days in Complic.UTI
   pneum., sinusit., compl.UTI & ac. pyelonephrit., uncomplic.UTI in   Special precautions: Prone to seiz., concom. fenbufen/NSAID’s   Adults: 400 mg 2xdly.
   women, uncomplic./complicat. skin & soft tiss.& intra-abdom.infects.  & meds.low.cerebr.seiz. threshold eg.theophyll., poss.false negat.   Contraindications: Creat.clear.&lt;30 ml/min., pre-pubert.childr.,
   in adults caus by sens.bact.  bacteriolog. TB diagn., expos.to strong sunlight/ UV, admin.2 hrs.  concom.didanosine.
   (S4) TABS, A40/20.1.1/0525, 0526  bef./aft.Fe salts/Al & Mg contain. antacids & sucralfate, discont.  Side effects: CNS eff., GI disturbs., neuropsych./ skin/hypersens.
   707946-001: 250 mg, 5, R66,04  if pseudomembr. colit. is suspect.& init.appropr.ther., porphyr.,   reacts., photosens., periph. neuropathy, pseudomembr.colit., crysta-
   707947-001: 500 mg, 5, R110,10  myasthen. grav.            lur., tendinit., arthralg., bld.dyscras.
   707947-002: 500 mg, 10, R220,30  Drug interactions: Fe salts/antacids & sucralfate reduc.absorpt.,   Special precautions: Add an aminoglycos. when treat.pseudomon.
   Dosage: Dos.determin.by sev., type & sens.of infect.  inhibit.hepat.drug metabol.poss. interfer. with clear.of meds.that low.  aeruginosa, elderly, convuls., imp.liv./ren.funct., G-6-PD defic.syndr.,
   RTI’s: 500 mg 1-2xdly.x5-14 days. High.dos.in pres. of complicat.fact.  seiz.thresh.eg. theophylline, fenbufen/ simil.NSAID’s.  adeq.fluid intake., CNS disord.hist., avoid strong sunlight, myasth.
   UTI’s: Complic: 250 mg 1xdly. x10 days. Uncomplic.in women: 250   grav.poss.aggrav., safety in pregn.& lactat. not est., monit.prothromb.
   mg 1xdly.x3 days.            TAVANIC, Ranbaxy [P/S]        time of pts.taking warfarin.
   Skin & soft tiss.infects: Uncomplic: 250-500 mg 1xdly. x7-10 days.   Levofloxacin.  Drug interactions: Antagon.of act.with nitrofurantoin, urin.alka-
   Complic: 500 mg 1xdly. x10-14 days.  Indications: Sinusit., ac.exacerbat.of chron. bronchit., community   lisers may reduc.solubility in urine, absorpt.reduc.by antacids, Fe
   Intra-abdom.infects: 500 mg 1xdly.in combinat. with anaerobic   acquir.pneum., hosp. acquir.pneum., chron.bact. prostatit., compl.UTI   sulfate, zinc and sucralfate, ser.creatinine & cyclosporin conc. rais.
   antibiot. x10-14 days. In pres.of bacteraem./ septicaem.incr.dos.  & ac.pyelonephrit., uncomplic. UTI in women, uncomplic.& complic.   by cyclosporin, probenecid incr.toxic.risk, anticoag. eff.of warfar.incr.
   to 500 mg 2xdly              skin & soft tiss.& intra-abdom. infects.in adults caus by sens. bact.  ZYBACT, Zydus [P/S]
   Contraindications: Epilep., tendon disord.hist. assoc.with fluroqui-  (S4) TABS, [P/S] 32/20.1.1/0123, 0124, 43/20.1.1/0947  Levofloxacin.
   nolone admin., childr./adolesc. und. 18 yrs., pregn., lactat.  845876-007: 250 mg, 5, R110,22  Indications: Ac.exacerbat.of chron. bronchit., community acquir.
   Side effects: GI disturbs.incl.sev./bloody diarrh., CNS effs., pares-  845884-026: 500 mg, 5, R184,61  pneum., sinusit., complic. UTI & ac.pyelonephrit., uncomplic. UTI in
   thes., vis.disturbs., imp.hear./ taste & smell, tremor, convuls., psychot.  845884-018: 500 mg, 10, R369,21  women, uncomplic. & complic.skin & soft tiss.& intra-abdom. infects.
   reacts., bld. dyscras., hepatit., interstit.nephrit., ac.kidn. fail., photo-  (S4) TABS, [P/S] 43/20.1.1/0947  in adults caus by sens.bact.
   sens., hypersens.reacts.incl.Stev.-Johns. /Lyell’s syndr., tendinit., ar-  Indications: Sinusit., ac.exacerbat.of chron. bronchit., community   (S4) TABS, 44/20.1.1/0250
   thralg./myalg., Achilles tend.rupt., musc.weakn.esp.in myasth. grav.   acquir.pneum., hosp. acquir.pneum.,  718709-001: 500 mg, 5, R153,50
   pts., rhabdomyolys., hypoglycaem., asthen., superinfect., trigg.pro-  720239-001: 750 mg, 5, R186,69  718709-002: 500 mg, 10, R307,00
   phyr.attacks in porphyr.pts., anaphylact.-like shock.  (S4) IV INFUS, [P/S] 34/20.1.1/0002; 32/20.1.1/0125; 43/20.1.1/0948.   Dosage: Swall.whole.Do not crush/chew. Dos. determin.by sev.,
   Special precautions: Seiz.disposit., concom. fenbufen/NSAID’s   5 mg/ml.  type & sens.of infect. Admin. concom.aminoglycosid. in P aerugi-
   & meds.low.cerebr.seiz. threshold eg.theophyll., poss.false negat.   885975-007: 250 mg, 1x 50 ml vial, R74,04  nosa infects.
   bacteriolog. TB diagn., unnecess.expos.to strong sunlight/ UV, tabs.  845892-002: 500 mg, 1x 100 ml vial, R116,36  Bronchit., bacter.exacerbat: 500 mg once dly x5-10 days.
   should be admin.2 hrs.bef./ aft. Fe salts/antacids & sucralfate, imp.  719227-001: 750 mg, 1x 150 ml vial, R207,39  Community acquir.pneumon: 500 mg 1-2xdly. x10-14 days. High.
   ren.funct., discont. if pseudomembr. colit.is suspect., diabet., por-  Dosage: Dos.determin.by sev., type & sens.of infect. Tabs: swallow   dos.in pres. of complicat.fact.
   phyr., myasth.grav.          whole without crush. Infus. (within 3 hrs.of perforat.of stopper) over   Sinusit: 500 mg once dly.x10-14 days.
   Drug interactions: Iron preps./Mg or Al hydrox. contain.antacids   not less than 30 mins.for 250 mg dos & over not less than 60 mins.for   UTI’s: Complic. & ac.pyelonephrit: 250 mg 1xdly. x10 days.
   & sucralfate interfer.with absorpt., inhibit.hepat.drug metabol.poss.  500 mg dos. & over not less than 90 mins.for 750 mg.  Uncomplic.UTI in women: 250 mg 1xdly. x3 days.
   interfer. with clear.of drugs that low.seiz.thresh.eg. theophylline,   Sinusit. & ac.exacerbat.of chron.bronchit: 500 mg once dly.  Uncomplic.skin & soft tiss.infects: 250-500 mg once dly. x7-10 days.
   fenbufen/simil.NSAID’s.      x5-10 days or                 Complic.skin & soft tiss.infects: 500 mg once dly. x10-14 days.
                                Ac.sinusit: 750 mg once dly x 5 days.  Intra-abdom.infects: 500 mg 1xdly.in combinat. with anaerobic
   TAFLOC, (Aspen Pharmacare: Pharma) Pharmacare [P/S]  Ac.exacerbat. of chron.bronchit: 750 mg once dly for 3-5 days.  antibiot. x10-14 days. In pres.of bacteraem./ septicaem.incr.dos.to
   Ofloxacin.                   Community acquir.pneumon: 500 mg 1-2xdly. x10-14 days or   500 mg 2xdly x10-14 days.
   Indications: LRTI, STD’s & UTI from suscept.bact.  750 mg once dly for 5 days. High. dos. in pres. of complicat.fact.  Contra-indications: Epilep., tendon disord. hist. relat.to fluroqui-
   (S4) TABS, [P/S] 35/20.1.1/0174, 0175  Hospit.acquir.pneumon: 750 mg once dly for 10-14 days.  nolone admin., pts.und. 18 yrs., pregn.& lactat.
   700731-009: 200 mg, 10, R154,96  Chron.bact.prostatit: 500 mg once dly.x28 days.  Side-effects: Hypoglycaem.esp.in diab.pts., porphyr.attacks in por-
   700733-003: 400 mg, 10, R303,53  UTI’s: Complic: 250 mg 1xdly. x10 days. Uncomplic. in women:   phyr.pts., bld.dyscras., hypersens.reacts.incl. angioed./ anaphylact.
   Dosage: Uncomplic.cystit: 100 mg 2xdly x3-7  days.  250 mg 1xdly.x3 days.  shock, skin disords.incl.Stev. John.syndr./tox.epiderm. necrolys./
   Pyelonephrit: 200 mg 2xdly.x 5-7 days.  Uncomplic.skin & soft tiss.infects: 250-500 mg once dly.   erythem. multiforme, psych.disords.i ncl.psychot. reacts., convuls.,
   LRTI: 400 mg 2x dly.x 7-10 days. Dly.dos.may be alter.depend.on   x7-10 days.  CNS effs., headache, dizzin., trem, paraesthes., vis./audit./taste/
   severity of infect.          Complic.skin & soft tiss.infects: 500 mg 2xdly. x10-14 days.  smell disturbs., QT prolongat., tachycard., oed., syncope, hot flush.,
   Gonorrh: 400 mg as sngl.dos.  Intra-abdom.infects: 500 mg 1xdly.in combinat. with anaerobic   hypotens., GI disturbs.incl.bloody diarrh., hepatit., liv.enzym.incr.,
   Urethrit.& cervicit.due to Chlamydia trachomat: 600 mg dly in   antibiot. x10-14 days. In pres.of bacteraem./ septicaem.incr.dos.to   jaund., photosens., sweat., tendinit., arthralg./myalg., rhabdomyolys.,
   div.dos.for up to 7 days.    500 mg 2xdly. x10-14 days.    musc.weakn. esp.in myasthen.grav.pts., interstit. nephrit., crystallur.,
   Contraindications: Pregn., lactat., cerebr. convuls. disords., epilept.,   Contraindications: Epilep., tendon disord.hist. relat.to fluroquinolo-  ac.ren.fail., gynaecomast., fev., allerg.pneumonit., asthen., superin-
   pre-exist.CNS les., childr./ adolesc.in growth phase, tendon disord.   ne admin., concom.ACE inhibit.& renin-angiotens.block.in mod.to   fect., Achilles tend.rupt.
   hist. relat.to fluoroquinolones, agents inhibit. peristalsis  sev.ren.impairm., childr./adolesc.und. 18 yrs., pregn., lactat., 750 mg   Special precautions: Seiz. disposit., concom. NSAIDs/meds.low.
   Side effects: Allerg./anaphylact.reacts., seiz., musc. co-ordinat.dis-  infus.also: not to be mix.with heparin/alkaline sols.  seiz.thresh., poss. false negat.bacteriolog. TB diagn., strong sunlight/
   turb., tendinit.esp.in elderly & concom. corticoster., musculoskelet.  Side effects: Prurit., skin rash, urticar., angioed., hypotens., ana-  UV expos., diab.mellit., INR monit.with concom. warfar., preps. cont.
   eff., CNS effs., paraesthes., periph.neuropathy, vis.& sens. disturbs.,   phylact.shock, photosensitisat., sev. bullous erupt., tox.epiderm.  iron salts/sucralfate /Mg/Al-contain. antacids not to be admin.2 hrs.
   psychot.reacts., musc.& joint pain., bld. dyscras., crystallur., interstit.  necrolys., Stev. John. syndr., erythema multiforme, GI disturbs.incl.   bef./aft. ther., joint developm.in grow.organ.advers.affect. in anim.
   nephrit., myalg., gynaecomast., CV effs., GI disturbs., may aggrav.   bloody diarrh., hypoglycaem., CNS effs., depress., psychot.reacts.  stud., imp.ren.funct., discont.ther.in case of psychot. reacts., discont.if
   myasth.grav., photosens.     incl.suic., paraesthes., tremor, agitat., convuls., vis./audit./taste   pseudomembr.colit.is susp.& init.appropr.antibiot.ther., discont.ther.if
   Special precautions: Imp.ren./liv.funct., elderly, strong sunlight,   & smell disturbs., arthralg./myalg., tendinit., Achilles tend. rupt.,   tendon rupt.susp.& init.treatm., elderly, concom. corticoster., discont.
   pseudomembr.colit., discont.if S&S of tendonit.develop.& rest Achil-  musc.weakn.esp.in myasthen.grav.pts., rhabdomyolys., incr.liv.en-  ther. in case of anaphylax. with appropr.med.treatm., avoid in case
   les tendons, may trigg.porphyr.attack in predispos.pts., concom. glib-  zym., hepatit., sev.liv.inj. incl.ac.liv.fail., bld.dyscras., loc.irrit.with   of QT prolong./relev.risk fact., avoid concom.class. 1a/111 antidys-
   enclamide/coumarin derivat   IV infus., asthen., superinfect., allerg.pneumonit., fev., hypersens.   rhythm. agents, concom. antihistam./ antimicrob.agents/phenothiaz./
   Drug interactions: Incr.in theophyll.lev., antacids contain. miner./  vasculit., porphyr.attacks in porphyr. pts., tachycard., electrocard.QT   TCA’s, gluc.-6-phosph.dehydrogenase defic., poss. sympt.exacerbat.
   iron preps.may imp.absorpt., incr. ser. conc.of glibenclamide, poss.  prolong., headache, dizzin., somnol., trem., dysgeus., paraesthes.,   in myasthen grav.pts.
   incr.in ser.lev.of meds. undergo.ren.tubul secret.eg. probenecid/ ci-  convuls., periph.sensory/-motor periph neuropathy, vertigo, dyspn.,   Drug interactions: Poss.glibenclamide eff. enhanc., warfar.lev.poss.
   metidine/ furosemide/methotrex., monit.pts.on concom. coumar.  bronchosp., ren.fail., mucocutan.reacts., extrapyramid. sympt./musc.  incr., poss. interfere with clear.of theophylline / NSAID’s that low.seiz.
   derivat.carefully.           co-ordinat.disords., phlebit.  thresh., iron salts/antacids/sucralfate reduc. absorpt.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page280.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page276.html">276</a>&nbsp;&nbsp;&nbsp;<a href="page277.html">277</a>&nbsp;&nbsp;&nbsp;<a href="page278.html">278</a>&nbsp;&nbsp;&nbsp;<a href="page279.html">279</a>&nbsp;&nbsp;&nbsp;<a href="page280.html">280</a>&nbsp;&nbsp;&nbsp;<a href="page281.html">281</a>&nbsp;&nbsp;&nbsp;<a href="page282.html">282</a>&nbsp;&nbsp;&nbsp;<a href="page283.html">283</a>&nbsp;&nbsp;&nbsp;<a href="page284.html">284</a>&nbsp;&nbsp;&nbsp;<a href="page285.html">285</a>&nbsp;&nbsp;&nbsp;<a href="page286.html">286</a>
             </td>
             <td width="35%"><a href="page282.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page282.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
